No profile data available.
Mangoceuticals, Inc. (MGRX) is a healthcare company in the multi-therapeutic drug manufacturing industry, based in Dallas, United States, with about 3 full-time employees.
It reported revenue of $456,021 for fiscal year 2025, down 26.0% from fiscal year 2024, and net income of -$21.82 million. In Q1 2026 (the quarter ended March 31, 2026) revenue was $67,864, down 37.9% from a year before. Its market capitalization was $9.10 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States.
Mangoceuticals reported $456,021 in revenue for fiscal year 2025, down 26.0% from $615,873 in fiscal year 2024. In Q1 2026 revenue was $67,864.
$9.10 million as of October 9, 2026.
Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Aptorum Group Limited (APM), Theriva Biologics, Inc. (TOVX), Senti Biosciences, Inc. (SNTI), Soligenix, Inc. (SNGX).